$CVS
CVS Health Corp

2016 Q4 Form 10-Q Financial Statement

#000006480316000097 Filed on November 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $45.97B $44.62B $38.64B
YoY Change 11.73% 15.45% 10.35%
Cost Of Revenue $36.23B $37.12B $31.98B
YoY Change 7.04% 16.07% 12.01%
Gross Profit $7.606B $7.492B $6.661B
YoY Change 4.18% 12.48% 2.98%
Gross Profit Margin 16.55% 16.79% 17.24%
Selling, General & Admin $4.563B $4.668B $4.330B
YoY Change -0.2% 7.81% 2.56%
% of Gross Profit 59.99% 62.31% 65.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.742B $4.675B $4.330B
YoY Change 47.46% 7.97% 2.56%
Operating Profit $2.995B $2.817B $2.331B
YoY Change 9.75% 20.85% 3.78%
Interest Expense -$262.0M $258.0M $268.0M
YoY Change -5.07% -3.73% 69.62%
% of Operating Profit -8.75% 9.16% 11.5%
Other Income/Expense, Net -$5.000M -$7.000M
YoY Change
Pretax Income $2.753B $2.463B $2.070B
YoY Change 12.23% 18.99% 31.68%
Income Tax $1.046B $921.0M $833.0M
% Of Pretax Income 37.99% 37.39% 40.24%
Net Earnings $1.707B $1.540B $1.246B
YoY Change 13.95% 23.6% 31.43%
Net Earnings / Revenue 3.71% 3.45% 3.22%
Basic Earnings Per Share $1.60 $1.44 $1.11
Diluted Earnings Per Share $1.59 $1.43 $1.11
COMMON SHARES
Basic Shares Outstanding 1.066B shares 1.068B shares 1.114B shares
Diluted Shares Outstanding 1.073B shares 1.121B shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.458B $2.263B $3.011B
YoY Change 35.77% -24.84% 148.84%
Cash & Equivalents $3.371B $2.189B $2.890B
Short-Term Investments $87.00M $74.00M $121.0M
Other Short-Term Assets $660.0M $703.0M $579.0M
YoY Change -8.59% 21.42% -10.09%
Inventory $14.76B $14.35B $13.28B
Prepaid Expenses
Receivables $12.16B $13.63B $12.80B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.04B $30.94B $30.75B
YoY Change 6.46% 0.6% 21.38%
LONG-TERM ASSETS
Property, Plant & Equipment $10.18B $9.901B $9.494B
YoY Change 3.25% 4.29% 9.2%
Goodwill $38.25B $38.21B $37.14B
YoY Change 0.38% 2.91% 31.91%
Intangibles $13.51B $13.57B $13.50B
YoY Change -2.64% 0.47% 37.04%
Long-Term Investments
YoY Change
Other Assets $1.485B $1.535B $1.476B
YoY Change 3.13% 4.0% -4.16%
Total Long-Term Assets $63.42B $63.22B $61.61B
YoY Change 0.22% 2.61% 27.72%
TOTAL ASSETS
Total Short-Term Assets $31.04B $30.94B $30.75B
Total Long-Term Assets $63.42B $63.22B $61.61B
Total Assets $94.46B $94.16B $92.36B
YoY Change 2.19% 1.94% 25.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.946B $7.584B $7.064B
YoY Change 6.09% 7.36% 17.09%
Accrued Expenses $6.937B $8.856B $6.636B
YoY Change 1.58% 33.45% 22.14%
Deferred Revenue
YoY Change
Short-Term Debt $1.874B $340.0M $0.00
YoY Change -100.0%
Long-Term Debt Due $42.00M $783.0M $451.0M
YoY Change -96.49% 73.61% -21.15%
Total Short-Term Liabilities $26.25B $26.74B $21.43B
YoY Change 13.3% 24.76% 17.69%
LONG-TERM LIABILITIES
Long-Term Debt $25.62B $25.61B $26.77B
YoY Change -2.48% -4.34% 128.64%
Other Long-Term Liabilities $1.549B $1.597B $1.528B
YoY Change 0.45% 4.52% 2.28%
Total Long-Term Liabilities $27.16B $1.597B $28.30B
YoY Change -2.32% -94.36% 1794.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.25B $26.74B $21.43B
Total Long-Term Liabilities $27.16B $1.597B $28.30B
Total Liabilities $53.41B $28.34B $49.73B
YoY Change 4.78% -43.02% 152.36%
SHAREHOLDERS EQUITY
Retained Earnings $38.98B $37.73B $34.40B
YoY Change 9.79% 9.69% 11.52%
Common Stock $17.00M $17.00M $17.00M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $33.45B $32.99B $27.90B
YoY Change 15.81% 18.25% 21.95%
Treasury Stock Shares 643.0M shares 638.0M shares 587.0M shares
Shareholders Equity $36.83B $35.95B $37.17B
YoY Change
Total Liabilities & Shareholders Equity $94.46B $94.16B $92.36B
YoY Change 2.19% 1.94% 25.53%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $1.707B $1.540B $1.246B
YoY Change 13.95% 23.6% 31.43%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $2.121B $3.934B $1.820B
YoY Change -40.6% 116.15% 10.64%
INVESTING ACTIVITIES
Capital Expenditures -$617.0M -$505.0M -$548.0M
YoY Change -29.65% -7.85% 0.55%
Acquisitions
YoY Change
Other Investing Activities -$201.0M $84.00M -$9.362B
YoY Change -86.97% -100.9% -4876.53%
Cash From Investing Activities -$818.0M -$421.0M -$9.910B
YoY Change -66.2% -95.75% 2739.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -121.0M -2.451B 9.743B
YoY Change -92.29% -125.16% -648.9%
NET CHANGE
Cash From Operating Activities 2.121B 3.934B 1.820B
Cash From Investing Activities -818.0M -421.0M -9.910B
Cash From Financing Activities -121.0M -2.451B 9.743B
Net Change In Cash 1.182B 1.062B 1.653B
YoY Change -382.1% -35.75% -445.09%
FREE CASH FLOW
Cash From Operating Activities $2.121B $3.934B $1.820B
Capital Expenditures -$617.0M -$505.0M -$548.0M
Free Cash Flow $2.738B $4.439B $2.368B
YoY Change -38.44% 87.46% 8.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 cvs Charitable Contributiontothe Cvs Foundation
CharitableContributiontotheCVSFoundation
32000000 USD
CY2015Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
7653000000 USD
CY2016Q3 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
9178000000 USD
CY2016Q2 cvs Debt Instrument Redemption Redemption Premium
DebtInstrumentRedemptionRedemptionPremium
486000000 USD
CY2016Q3 cvs Debt Instrument Redemption Redemption Premium
DebtInstrumentRedemptionRedemptionPremium
97000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
-184000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
119000000 USD
CY2016Q3 cvs Guaranteed Store Leases
GuaranteedStoreLeases
87 store_lease
CY2015Q4 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
1197000000 USD
CY2016Q3 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
783000000 USD
CY2015Q4 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
26267000000 USD
CY2016Q3 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
25610000000 USD
CY2015Q3 cvs Loss Contingency Cases Consolidated Number
LossContingencyCasesConsolidatedNumber
2 class_action_complaint
cvs Paymentfor Contingent Consideration
PaymentforContingentConsideration
0 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.32
CY2010Q1 cvs Number Of States Participating In Multistate Investigations
NumberOfStatesParticipatingInMultistateInvestigations
28 state
cvs Paymentfor Contingent Consideration
PaymentforContingentConsideration
26000000 USD
cvs Proceedsfrom Saleof Property Plantand Equipmentand Other Assets
ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets
28000000 USD
cvs Proceedsfrom Saleof Property Plantand Equipmentand Other Assets
ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets
22000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
0 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
39000000 USD
cvs Yearthe Last Lease Expires
YeartheLastLeaseExpires
2047
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1066439174 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CVS HEALTH CORPORATION
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7490000000 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7584000000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11888000000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13625000000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6829000000 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8856000000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-358000000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-319000000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30948000000 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31541000000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
87000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
175000000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
166000000 USD
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000 shares
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000 shares
CY2015Q4 us-gaap Assets
Assets
92437000000 USD
CY2016Q3 us-gaap Assets
Assets
94156000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
29158000000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
30939000000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2481000000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2890000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2459000000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2189000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
409000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-270000000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.29
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.350
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.050
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.425
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.275
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2015Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2016Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2015Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2016Q3 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1699000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1705000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1101000000 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1066000000 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1185000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3640000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1538000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3649000000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1186000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3641000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1539000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3651000000 USD
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
31983000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
92917000000 USD
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
37123000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
110304000000 USD
CY2016Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
26400000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4217000000 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4254000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1510000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1847000000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.32
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.34
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
132000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
72000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4709000000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5303000000 USD
CY2015Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-101000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-643000000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
38106000000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
38214000000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
6661000000 USD
us-gaap Gross Profit
GrossProfit
19227000000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
7492000000 USD
us-gaap Gross Profit
GrossProfit
21251000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1230000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3711000000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1534000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3593000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2070000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6163000000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2463000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5884000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1237000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3730000000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1542000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3613000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.10
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.31
CY2016Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.44
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.34
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.10
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.28
CY2016Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.43
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.32
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
10000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
10000000 USD
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
37000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-100000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-61000000 USD
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
833000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2433000000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
921000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2271000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2305000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2194000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2038000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1570000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2530000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1714000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
523000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2077000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
893000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
337000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-591000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
86000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-116000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
49000000 USD
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
CY2015Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6398000000 USD
CY2016Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6398000000 USD
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
18587000000 USD
CY2016Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
18870000000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13878000000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13567000000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
268000000 USD
us-gaap Interest Expense
InterestExpense
577000000 USD
CY2016Q3 us-gaap Interest Expense
InterestExpense
258000000 USD
us-gaap Interest Expense
InterestExpense
830000000 USD
CY2015Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-261000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-562000000 USD
CY2016Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-253000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-816000000 USD
us-gaap Interest Paid
InterestPaid
423000000 USD
us-gaap Interest Paid
InterestPaid
954000000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
14001000000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
14348000000 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
15000000 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
14000000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92437000000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94156000000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23169000000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26741000000 USD
CY2016Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
3500000 USD
CY2016Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
28700000000 USD
CY2003Q4 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
3 class_action_complaint
CY2015Q3 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 class_action_complaint
CY2003Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 defendant
CY2015Q4 us-gaap Minority Interest
MinorityInterest
7000000 USD
CY2016Q3 us-gaap Minority Interest
MinorityInterest
5000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6576000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6568000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11000000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1652000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4841000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7948000000 USD
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1246000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3739000000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1540000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3610000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
4330000000 USD
us-gaap Operating Expenses
OperatingExpenses
12502000000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
4675000000 USD
us-gaap Operating Expenses
OperatingExpenses
13908000000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2331000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6725000000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2817000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
7343000000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
722000000 USD
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
703000000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1440000000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1535000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-61000000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-99000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-99000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1542000000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1597000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3871000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000000000 USD
CY2016Q2 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
6000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1185000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1384000000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
184000000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
40000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9503000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
333000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1490000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1607000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
89530000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
106371000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
11240000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
11092000000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
108324000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
128545000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
15000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
14000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14808000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3455000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-685000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
340000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
115000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
76000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
277000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
205000000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
1247000000 USD
us-gaap Profit Loss
ProfitLoss
3740000000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
1541000000 USD
us-gaap Profit Loss
ProfitLoss
3612000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9855000000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9901000000 USD
CY2015Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
CY2016Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2000000 USD
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39000000 USD
CY2016Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 USD
CY2015Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
16000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
37000000 USD
CY2016Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
7000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
29000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2898000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5185000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35506000000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37732000000 USD
CY2015Q3 us-gaap Revenues
Revenues
38644000000 USD
us-gaap Revenues
Revenues
112144000000 USD
CY2016Q3 us-gaap Revenues
Revenues
44615000000 USD
us-gaap Revenues
Revenues
131555000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
34000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
230000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
175000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
166000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.02
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24000000 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
68.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
104.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y11M9D
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2016Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
340000000 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
88000000 USD
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
74000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
37196000000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
35949000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37203000000 USD
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35954000000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
597000000 shares
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
638000000 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
28886000000 USD
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
32991000000 USD
CY2015Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6000000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
18000000 USD
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
7000000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
18000000 USD
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1121000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1130000000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1073000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1082000000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1114000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1122000000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1068000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1076000000 shares
CY2016Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
50000000 USD
CY2016Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
4000000 USD

Files In Submission

Name View Source Status
0000064803-16-000097-index-headers.html Edgar Link pending
0000064803-16-000097-index.html Edgar Link pending
0000064803-16-000097.txt Edgar Link pending
0000064803-16-000097-xbrl.zip Edgar Link pending
a1282016cvslogoa02.gif Edgar Link pending
cvs-20160930.xml Edgar Link completed
cvs-20160930.xsd Edgar Link pending
cvs-20160930_cal.xml Edgar Link unprocessable
cvs-20160930_def.xml Edgar Link unprocessable
cvs-20160930_lab.xml Edgar Link unprocessable
cvs-20160930_pre.xml Edgar Link unprocessable
cvs20160930-10q.htm Edgar Link pending
cvs20160930ex311.htm Edgar Link pending
cvs20160930ex312.htm Edgar Link pending
cvs20160930ex321.htm Edgar Link pending
cvs20160930ex322.htm Edgar Link pending
exhibit151q316eyconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending